about
Hepatocyte transplantation program: Lessons learned and future strategiesHuman regeneration: An achievable goal or a dream?Alginate: properties and biomedical applications.Impact of alginate composition: from bead mechanical properties to encapsulated HepG2/C3A cell activities for in vivo implantation.Hepatogenic differentiation of mesenchymal stem cells induced by insulin like growth factor-I.Technology insight: liver support systems.Transplantation of hESC-derived hepatocytes protects mice from liver injury.The use of cellular technologies in treatment of liver pathologies.Bioartificial liver systems: why, what, whither?Portocaval shunt for hepatocyte package: challenging application of small intestinal graft in animal models.Use of hepatocyte and stem cells for treatment of post-resectional liver failure: are we there yet?Promising perspectives towards regrowing a human arm.Decrease of global methylation improves significantly hepatic differentiation of Ad-MSCs: possible future application for urea detoxification.External inosculation as a feature of revascularization occurs after free transplantation of murine liver grafts.Blood-derived stem cells (BDSCs) plasticity: in vitro hepatic differentiation.Rating of CCl(4)-induced rat liver fibrosis by blood serum glycomics.Bioartificial liver system based on choanoid fluidized bed bioreactor improve the survival time of fulminant hepatic failure pigs.Determining the origin of cells in tissue engineered skin substitutes: a pilot study employing in situ hybridization.Clinical Outcome of Hepatocyte Transplantation in Four Pediatric Patients with Inherited Metabolic Diseases
P2860
Q26774608-D691CA82-6A29-4043-BF61-FD3174C9A7C0Q28072510-ADC2658B-6F1E-46EA-9C64-6C323DFD9C62Q34236679-D32EC403-4FF5-46B3-9ADF-6D7E7AE5CE08Q34700868-FC676DDF-179F-4297-968B-A393B6249D18Q35653315-69ED04A9-A33F-4438-8AF1-E8E54E5E0C51Q36304257-BC08D3AB-B680-4F56-8C68-879E177D9CC7Q36366073-F333A939-7E9C-4D6D-A326-AAE98BAC5AC8Q36379723-6F50A342-AACA-45D7-9725-72FC6AA7F6AFQ37202810-354F7C94-BCE0-4CC2-BCB7-FEFE846E83D9Q37521350-FC9962F5-599D-418C-B1E5-AC9D6A472E31Q37885457-83233444-E3A4-443A-82A9-4CECABEE624AQ39342404-9B858EBC-70C2-4E6B-A125-A3999D32BF07Q39628659-11200C08-30F4-4A0C-B172-DBD175BE39BBQ44738565-49083081-9ED4-4BCB-A3C2-568E4F0A3346Q46437473-9891D578-5A7A-4B22-B319-6B44803E006FQ49050083-C844E7A7-B27E-456C-B7BA-1B9C2DF5F8C4Q53257170-B86D22E5-D7DE-4EA6-9DEA-C3154593AD96Q54402121-5B1E24A6-0086-4489-8A3A-253498B56D74Q58680778-E3D036EB-0EFA-4D54-A3E8-39829787002D
P2860
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Cellular therapies for liver replacement.
@ast
Cellular therapies for liver replacement.
@en
type
label
Cellular therapies for liver replacement.
@ast
Cellular therapies for liver replacement.
@en
prefLabel
Cellular therapies for liver replacement.
@ast
Cellular therapies for liver replacement.
@en
P1476
Cellular therapies for liver replacement.
@en
P2093
Clare Selden
Humphrey Hodgson
P304
P356
10.1016/J.TRIM.2003.12.008
P577
2004-04-01T00:00:00Z